{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T16:06:26Z","timestamp":1783181186714,"version":"3.54.6"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2021,11,23]],"date-time":"2021-11-23T00:00:00Z","timestamp":1637625600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,11,23]],"date-time":"2021-11-23T00:00:00Z","timestamp":1637625600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100004608","name":"Natural Science Foundation of Jiangsu Province","doi-asserted-by":"publisher","award":["BK20211105"],"award-info":[{"award-number":["BK20211105"]}],"id":[{"id":"10.13039\/501100004608","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013058","name":"jiangsu provincial key research and development program","doi-asserted-by":"publisher","award":["BE2019692"],"award-info":[{"award-number":["BE2019692"]}],"id":[{"id":"10.13039\/501100013058","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010031","name":"postdoctoral research foundation of china","doi-asserted-by":"publisher","award":["2019M661909"],"award-info":[{"award-number":["2019M661909"]}],"id":[{"id":"10.13039\/501100010031","id-type":"DOI","asserted-by":"publisher"}]},{"name":"the health project of jiangsu province","award":["H2019072"],"award-info":[{"award-number":["H2019072"]}]},{"name":"social development foundation of nantong city","award":["MSZ20076"],"award-info":[{"award-number":["MSZ20076"]}]},{"name":"social development foundation of nantong city","award":["JCZ20065"],"award-info":[{"award-number":["JCZ20065"]}]},{"name":"social development foundation of nantong city","award":["MS12020018"],"award-info":[{"award-number":["MS12020018"]}]},{"name":"social development foundation of nantong city","award":["MSZ19177"],"award-info":[{"award-number":["MSZ19177"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Transl Oncol"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1007\/s12094-021-02705-7","type":"journal-article","created":{"date-parts":[[2021,11,23]],"date-time":"2021-11-23T03:02:22Z","timestamp":1637636542000},"page":"517-531","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":32,"title":["Human umbilical cord mesenchymal stem cell-derived exosomes carrying hsa-miRNA-128-3p suppress pancreatic ductal cell carcinoma by inhibiting Galectin-3"],"prefix":"10.1007","volume":"24","author":[{"given":"X.","family":"Xie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"X.","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W.","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W.","family":"Sai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Z.","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3372-1069","authenticated-orcid":false,"given":"M.","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Bao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,11,23]]},"reference":[{"issue":"1","key":"2705_CR1","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21442","volume":"68","author":"RL Siegel","year":"2018","unstructured":"Siegel RL, Miller KD, Jemal A. Cancer statistics, 2018. CA Cancer J Clin. 2018;68(1):7\u201330. https:\/\/doi.org\/10.3322\/caac.21442.","journal-title":"CA Cancer J Clin"},{"issue":"10242","key":"2705_CR2","doi-asserted-by":"publisher","first-page":"2008","DOI":"10.1016\/S0140-6736(20)30974-0","volume":"395","author":"JD Mizrahi","year":"2020","unstructured":"Mizrahi JD, Surana R, Valle JW, et al. Pancreatic cancer. Lancet. 2020;395(10242):2008\u201320. https:\/\/doi.org\/10.1016\/S0140-6736(20)30974-0.","journal-title":"Lancet"},{"issue":"2","key":"2705_CR3","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1002\/ijc.30670","volume":"141","author":"B Zhou","year":"2017","unstructured":"Zhou B, Xu JW, Cheng YG, et al. Early detection of pancreatic cancer: Where are we now and where are we going? Int J Cancer. 2017;141(2):231\u201341. https:\/\/doi.org\/10.1002\/ijc.30670.","journal-title":"Int J Cancer"},{"issue":"3","key":"2705_CR4","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1007\/s10456-014-9420-y","volume":"17","author":"NS Vasudev","year":"2014","unstructured":"Vasudev NS, Reynolds AR. Anti-angiogenic therapy for cancer: current progress, unresolved questions and future directions. Angiogenesis. 2014;17(3):471\u201394. https:\/\/doi.org\/10.1007\/s10456-014-9420-y.","journal-title":"Angiogenesis"},{"issue":"4","key":"2705_CR5","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1007\/bf01372555","volume":"120","author":"PB Desai","year":"1994","unstructured":"Desai PB. Understanding the biology of cancer\u2014has this any impact on treatment. J Cancer Res Clin Oncol. 1994;120(4):193\u20139. https:\/\/doi.org\/10.1007\/bf01372555.","journal-title":"J Cancer Res Clin Oncol"},{"issue":"4","key":"2705_CR6","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1159\/000339610","volume":"17","author":"I Cetin","year":"2012","unstructured":"Cetin I, Topcul M. Cancer stem cells in oncology. Eur Surg Res. 2012;17(4):644\u20138. https:\/\/doi.org\/10.1159\/000339610.","journal-title":"Eur Surg Res"},{"issue":"5","key":"2705_CR7","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1016\/j.jcyt.2019.01.001","volume":"21","author":"X Xie","year":"2019","unstructured":"Xie X, Wu H, Li M, et al. Progress in the application of exosomes as therapeutic vectors in tumor-targeted therapy. Cytotherapy. 2019;21(5):509\u201324. https:\/\/doi.org\/10.1016\/j.jcyt.2019.01.001.","journal-title":"Cytotherapy"},{"issue":"1","key":"2705_CR8","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1007\/s12015-010-9168-8","volume":"7","author":"CG Fan","year":"2011","unstructured":"Fan CG, Zhang QJ, Zhou JR. Therapeutic potentials of mesenchymal stem cells derived from human umbilical cord. Stem Cell Rev Rep. 2011;7(1):195\u2013207. https:\/\/doi.org\/10.1007\/s12015-010-9168-8.","journal-title":"Stem Cell Rev Rep"},{"issue":"7","key":"2705_CR9","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.1634\/stemcells.2004-0013","volume":"22","author":"HS Wang","year":"2004","unstructured":"Wang HS, Hung SC, Peng ST, et al. Mesenchymal stem cells in the Wharton\u2019s jelly of the human umbilical cord. Stem Cells. 2004;22(7):1330\u20137. https:\/\/doi.org\/10.1634\/stemcells.2004-0013.","journal-title":"Stem Cells"},{"issue":"24","key":"2705_CR10","doi-asserted-by":"publisher","first-page":"4504","DOI":"10.3760\/cma.j.issn.0366-6999.2012.24.032","volume":"125","author":"DR Li","year":"2012","unstructured":"Li DR, Cai JH. Methods of isolation, expansion, differentiating induction and preservation of human umbilical cord mesenchymal stem cells. Chin Med J. 2012;125(24):4504\u201310. https:\/\/doi.org\/10.3760\/cma.j.issn.0366-6999.2012.24.032.","journal-title":"Chin Med J"},{"issue":"3","key":"2705_CR11","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1007\/s10571-016-0366-z","volume":"36","author":"ER Abels","year":"2016","unstructured":"Abels ER, Breakefield XO. Introduction to extracellular vesicles: biogenesis RNA cargo selection, content, release, and uptake. Cell Mol Neurobiol. 2016;36(3):301\u201312. https:\/\/doi.org\/10.1007\/s10571-016-0366-z.","journal-title":"Cell Mol Neurobiol"},{"key":"2705_CR12","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0068753","author":"S Khan","year":"2013","unstructured":"Khan S, Brougham CL, Ryan J, et al. miR-379 regulates cyclin b1 expression and is decreased in breast cancer. PLoS ONE. 2013. https:\/\/doi.org\/10.1371\/journal.pone.0068753.","journal-title":"PLoS ONE"},{"issue":"1","key":"2705_CR13","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.canlet.2016.02.043","volume":"375","author":"JS Chen","year":"2016","unstructured":"Chen JS, Li HS, Huang JQ, et al. MicroRNA-379-5p inhibits tumor invasion and metastasis by targeting FAK\/AKT signaling in hepatocellular carcinoma. Cancer Lett. 2016;375(1):73\u201383. https:\/\/doi.org\/10.1016\/j.canlet.2016.02.043.","journal-title":"Cancer Lett"},{"issue":"2","key":"2705_CR14","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1111\/jcmm.12966","volume":"21","author":"Z Li","year":"2017","unstructured":"Li Z, Shen JX, Chan MTV, et al. MicroRNA-379 suppresses osteosarcoma progression by targeting PDK1. J Cell Mol Med. 2017;21(2):315\u201323. https:\/\/doi.org\/10.1111\/jcmm.12966.","journal-title":"J Cell Mol Med"},{"key":"2705_CR15","doi-asserted-by":"publisher","DOI":"10.1038\/s41388-017-0116-9","author":"KP O\u2019Brien","year":"2018","unstructured":"O\u2019Brien KP, Khan S, Gilligan KE, et al. Employing mesenchymal stem cells to support tumor-targeted delivery of extracellular vesicle (EV)-encapsulated microRNA-379. Oncogene. 2018. https:\/\/doi.org\/10.1038\/s41388-017-0116-9.","journal-title":"Oncogene"},{"issue":"6","key":"2705_CR16","doi-asserted-by":"publisher","first-page":"8687","DOI":"10.3892\/ol.2018.8397","volume":"15","author":"Z Li","year":"2018","unstructured":"Li Z, Ni J, Song D, et al. Regulatory mechanism of microRNA-128 in osteosarcoma tumorigenesis and evolution through targeting SASH1. Oncol Lett. 2018;15(6):8687\u201394. https:\/\/doi.org\/10.3892\/ol.2018.8397.","journal-title":"Oncol Lett"},{"issue":"3","key":"2705_CR17","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1016\/s0002-9440(10)63177-x","volume":"164","author":"KK Hoyer","year":"2004","unstructured":"Hoyer KK, Pang M, Gui D, et al. An anti-apoptotic role for galectin-3 in diffuse large B-cell lymphomas. Am J Pathol. 2004;164(3):893\u2013902. https:\/\/doi.org\/10.1016\/s0002-9440(10)63177-x.","journal-title":"Am J Pathol"},{"issue":"3","key":"2705_CR18","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1016\/s0002-9440(10)64959-0","volume":"156","author":"P Nangia-Makker","year":"2000","unstructured":"Nangia-Makker P, Honjo Y, Sarvis R, et al. Galectin-3 induces endothelial cell morphogenesis and angiogenesis. Am J Pathol. 2000;156(3):899\u2013909. https:\/\/doi.org\/10.1016\/s0002-9440(10)64959-0.","journal-title":"Am J Pathol"},{"key":"2705_CR19","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0042699","author":"SM Song","year":"2012","unstructured":"Song SM, Ji BA, Ramachandran V, et al. Overexpressed galectin-3 in pancreatic cancer induces cell proliferation and invasion by binding Ras and activating Ras signaling. PLoS ONE. 2012. https:\/\/doi.org\/10.1371\/journal.pone.0042699.","journal-title":"PLoS ONE"},{"issue":"22","key":"2705_CR20","doi-asserted-by":"publisher","first-page":"2514","DOI":"10.1038\/onc.2010.631","volume":"30","author":"J Merlin","year":"2011","unstructured":"Merlin J, Stechly L, de Beauce S, et al. Galectin-3 regulates MUC1 and EGFR cellular distribution and EGFR downstream pathways in pancreatic cancer cells. Oncogene. 2011;30(22):2514\u201325. https:\/\/doi.org\/10.1038\/onc.2010.631.","journal-title":"Oncogene"},{"key":"2705_CR21","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.carbpol.2018.10.008","volume":"204","author":"YL Yao","year":"2019","unstructured":"Yao YL, Zhou LS, Liao WF, et al. HH1\u20131, a novel Galectin-3 inhibitor, exerts anti-pancreatic cancer activity by blocking Galectin-3\/EGFR\/AKT\/FOXO3 signaling pathway. Carbohydr Polym. 2019;204:111\u201323. https:\/\/doi.org\/10.1016\/j.carbpol.2018.10.008.","journal-title":"Carbohydr Polym"},{"issue":"6","key":"2705_CR22","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1007\/s00432-012-1178-2","volume":"138","author":"L Xie","year":"2012","unstructured":"Xie L, Ni WK, Chen XD, et al. The expressions and clinical significances of tissue and serum galectin-3 in pancreatic carcinoma. J Cancer Res Clin Oncol. 2012;138(6):1035\u201343. https:\/\/doi.org\/10.1007\/s00432-012-1178-2.","journal-title":"J Cancer Res Clin Oncol"},{"issue":"2","key":"2705_CR23","doi-asserted-by":"publisher","first-page":"188409","DOI":"10.1016\/j.bbcan.2020.188409","volume":"1875","author":"G Luo","year":"2021","unstructured":"Luo G, Jin K, Deng S, et al. Roles of CA19\u20139 in pancreatic cancer: biomarker, predictor and promoter. Biochim Biophys Acta Rev Cancer. 2021;1875(2):188409. https:\/\/doi.org\/10.1016\/j.bbcan.2020.188409.","journal-title":"Biochim Biophys Acta Rev Cancer"},{"issue":"10039","key":"2705_CR24","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/S0140-6736(16)00141-0","volume":"388","author":"T Kamisawa","year":"2016","unstructured":"Kamisawa T, Wood LD, Itoi T, et al. Pancreatic cancer. Lancet (London, England). 2016;388(10039):73\u201385. https:\/\/doi.org\/10.1016\/S0140-6736(16)00141-0.","journal-title":"Lancet (London, England)"},{"issue":"2","key":"2705_CR25","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1007\/s12253-011-9444-1","volume":"18","author":"MM Gaida","year":"2012","unstructured":"Gaida MM, Bach ST, Guenther F, et al. Expression of galectin-3 in pancreatic ductal adenocarcinoma. Pathol Oncol Res. 2012;18(2):299\u2013307. https:\/\/doi.org\/10.1007\/s12253-011-9444-1.","journal-title":"Pathol Oncol Res"},{"key":"2705_CR26","doi-asserted-by":"publisher","DOI":"10.1111\/jcmm.15775","author":"N Yi","year":"2020","unstructured":"Yi N, Zhao X, Ji J, et al. Serum galectin-3 as a biomarker for screening, early diagnosis, prognosis and therapeutic effect evaluation of pancreatic cancer. J Cell Mol Med. 2020. https:\/\/doi.org\/10.1111\/jcmm.15775.","journal-title":"J Cell Mol Med"},{"key":"2705_CR27","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1007\/978-1-4939-3584-0_14","volume":"1416","author":"K Bieback","year":"2016","unstructured":"Bieback K, Netsch P. Isolation, culture, and characterization of human umbilical cord blood-derived mesenchymal stromal cells. Methods Mol Biol (Clifton, NJ). 2016;1416:245\u201358. https:\/\/doi.org\/10.1007\/978-1-4939-3584-0_14.","journal-title":"Methods Mol Biol (Clifton, NJ)"},{"issue":"4","key":"2705_CR28","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1002\/hep.24504","volume":"54","author":"T Kogure","year":"2011","unstructured":"Kogure T, Lin WL, Yan IK, et al. Intercellular nanovesicle-mediated microRNA transfer: a mechanism of environmental modulation of hepatocellular cancer cell growth. Hepatology. 2011;54(4):1237\u201348. https:\/\/doi.org\/10.1002\/hep.24504.","journal-title":"Hepatology"},{"issue":"3","key":"2705_CR29","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1016\/j.jconrel.2013.09.015","volume":"172","author":"Y Zhang","year":"2013","unstructured":"Zhang Y, Wang Z, Gemeinhart RA. Progress in microRNA delivery. J Control Release Off J Control Release Soc. 2013;172(3):962\u201374. https:\/\/doi.org\/10.1016\/j.jconrel.2013.09.015.","journal-title":"J Control Release Off J Control Release Soc"},{"issue":"9","key":"2705_CR30","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1093\/jjco\/hyq035","volume":"40","author":"N Saijo","year":"2010","unstructured":"Saijo N. Progress in cancer chemotherapy with special stress on molecular-targeted therapy. Jap J Clin Oncol. 2010;40(9):855\u201362. https:\/\/doi.org\/10.1093\/jjco\/hyq035.","journal-title":"Jap J Clin Oncol"},{"issue":"11","key":"2705_CR31","doi-asserted-by":"publisher","first-page":"1774","DOI":"10.1200\/jco.2007.15.7438","volume":"26","author":"RK Oldham","year":"2008","unstructured":"Oldham RK, Dillman RO. Monoclonal antibodies in cancer therapy: 25 years of progress. J Clin Oncol. 2008;26(11):1774\u20137. https:\/\/doi.org\/10.1200\/jco.2007.15.7438.","journal-title":"J Clin Oncol"},{"issue":"5","key":"2705_CR32","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1038\/nrd2241","volume":"6","author":"JM Reichert","year":"2007","unstructured":"Reichert JM, Valge-Archer VE. Outlook\u2014development trends for monoclonal antibody cancer therapeutics. Nat Rev Drug Discov. 2007;6(5):349\u201356. https:\/\/doi.org\/10.1038\/nrd2241.","journal-title":"Nat Rev Drug Discov"},{"issue":"1","key":"2705_CR33","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1097\/00000441-200207000-00004","volume":"324","author":"M Berger","year":"2002","unstructured":"Berger M, Shankar V, Vafai A. Therapeutic applications of monoclonal antibodies. Am J Med Sci. 2002;324(1):14\u201330. https:\/\/doi.org\/10.1097\/00000441-200207000-00004.","journal-title":"Am J Med Sci"},{"issue":"4","key":"2705_CR34","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1038\/nrc3236","volume":"12","author":"AM Scott","year":"2012","unstructured":"Scott AM, Wolchok JD, Old LJ. Antibody therapy of cancer. Nat Rev Cancer. 2012;12(4):278\u201387. https:\/\/doi.org\/10.1038\/nrc3236.","journal-title":"Nat Rev Cancer"},{"key":"2705_CR35","doi-asserted-by":"publisher","DOI":"10.1186\/1756-8722-5-70","author":"MA Firer","year":"2012","unstructured":"Firer MA, Gellerman G. Targeted drug delivery for cancer therapy: the other side of antibodies. J Hematol Oncol. 2012. https:\/\/doi.org\/10.1186\/1756-8722-5-70.","journal-title":"J Hematol Oncol"},{"issue":"1","key":"2705_CR36","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.jconrel.2006.04.014","volume":"114","author":"H Lv","year":"2006","unstructured":"Lv H, Zhang S, Wang B, et al. Toxicity of cationic lipids and cationic polymers in gene delivery. J Control Release. 2006;114(1):100\u20139. https:\/\/doi.org\/10.1016\/j.jconrel.2006.04.014.","journal-title":"J Control Release"},{"issue":"5","key":"2705_CR37","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1038\/nrg1066","volume":"4","author":"CE Thomas","year":"2003","unstructured":"Thomas CE, Ehrhardt A, Kay MA. Progress and problems with the use of viral vectors for gene therapy. Nat Rev Genet. 2003;4(5):346\u201358. https:\/\/doi.org\/10.1038\/nrg1066.","journal-title":"Nat Rev Genet"},{"issue":"7","key":"2705_CR38","doi-asserted-by":"publisher","first-page":"539","DOI":"10.2165\/00003088-200140070-00005","volume":"40","author":"JM Harris","year":"2001","unstructured":"Harris JM, Martin NE, Modi M. Pegylation\u2014a novel process for modifying pharmacokinetics. Clin Pharmacokinet. 2001;40(7):539\u201351. https:\/\/doi.org\/10.2165\/00003088-200140070-00005.","journal-title":"Clin Pharmacokinet"},{"issue":"11","key":"2705_CR39","doi-asserted-by":"publisher","first-page":"2060","DOI":"10.1016\/j.biocel.2012.08.007","volume":"44","author":"C Bang","year":"2012","unstructured":"Bang C, Thum T. Exosomes: new players in cell-cell communication. Int J Biochem Cell Biol. 2012;44(11):2060\u20134. https:\/\/doi.org\/10.1016\/j.biocel.2012.08.007.","journal-title":"Int J Biochem Cell Biol"},{"issue":"4","key":"2705_CR40","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1038\/nbt.1830","volume":"29","author":"JG van den Boorn","year":"2011","unstructured":"van den Boorn JG, Schlee M, Coch C, et al. SiRNA delivery with exosome nanoparticles. Nat Biotechnol. 2011;29(4):325\u20136. https:\/\/doi.org\/10.1038\/nbt.1830.","journal-title":"Nat Biotechnol"},{"issue":"4","key":"2705_CR41","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1038\/nbt.1807","volume":"29","author":"L Alvarez-Erviti","year":"2011","unstructured":"Alvarez-Erviti L, Seow YQ, Yin HF, et al. Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes. Nat Biotechnol. 2011;29(4):341-U179. https:\/\/doi.org\/10.1038\/nbt.1807.","journal-title":"Nat Biotechnol"},{"issue":"2","key":"2705_CR42","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1111\/tra.12352","volume":"17","author":"B Holder","year":"2016","unstructured":"Holder B, Jones T, Shimizu VS, et al. Macrophage exosomes induce placental inflammatory cytokines: a novel mode of maternal-placental messaging. Traffic. 2016;17(2):168\u201378. https:\/\/doi.org\/10.1111\/tra.12352.","journal-title":"Traffic"},{"issue":"1","key":"2705_CR43","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1016\/j.bbrc.2016.12.097","volume":"483","author":"RJ Shi","year":"2017","unstructured":"Shi RJ, Zhao LB, Cai WB, et al. Maternal exosomes in diabetes contribute to the cardiac development deficiency. Biochem Biophys Res Commun. 2017;483(1):602\u20138. https:\/\/doi.org\/10.1016\/j.bbrc.2016.12.097.","journal-title":"Biochem Biophys Res Commun"},{"issue":"5","key":"2705_CR44","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1038\/bjc.2014.14","volume":"110","author":"M Wang","year":"2014","unstructured":"Wang M, Zhao C, Shi H, et al. Deregulated microRNAs in gastric cancer tissue-derived mesenchymal stem cells: novel biomarkers and a mechanism for gastric cancer. Br J Cancer. 2014;110(5):1199\u2013210. https:\/\/doi.org\/10.1038\/bjc.2014.14.","journal-title":"Br J Cancer"},{"issue":"8","key":"2705_CR45","doi-asserted-by":"publisher","first-page":"1566","DOI":"10.3390\/jcm4081566","volume":"4","author":"J Matsuzaki","year":"2015","unstructured":"Matsuzaki J, Suzuki H. Role of microRNAs-221\/222 in digestive systems. J Clin Med. 2015;4(8):1566\u201377. https:\/\/doi.org\/10.3390\/jcm4081566.","journal-title":"J Clin Med"},{"key":"2705_CR46","doi-asserted-by":"publisher","first-page":"4161","DOI":"10.2147\/ott.S143315","volume":"10","author":"M Ma","year":"2017","unstructured":"Ma M, Chen SL, Liu Z, et al. miRNA-221 of exosomes originating from bone marrow mesenchymal stem cells promotes oncogenic activity in gastric cancer. Onco Targets Ther. 2017;10:4161\u201371. https:\/\/doi.org\/10.2147\/ott.S143315.","journal-title":"Onco Targets Ther"}],"container-title":["Clinical and Translational Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12094-021-02705-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12094-021-02705-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12094-021-02705-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,28]],"date-time":"2022-02-28T16:06:32Z","timestamp":1646064392000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12094-021-02705-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,23]]},"references-count":46,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,3]]}},"alternative-id":["2705"],"URL":"https:\/\/doi.org\/10.1007\/s12094-021-02705-7","relation":{},"ISSN":["1699-048X","1699-3055"],"issn-type":[{"value":"1699-048X","type":"print"},{"value":"1699-3055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,23]]},"assertion":[{"value":"22 June 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 August 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 November 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}